Dr. Wendy Wai Yeng Yeo is currently a lecturer in Biochemistry and Genetics at Perdana University Graduate School of Medicine, Perdana University, Malaysia. She completed her PhD from Universiti Putra Malaysia in Medical Biotechnology with a joint degree (co-tutelle) with Université de Montpellier, France in Health Biology. She did her MSc (Medical Biotechnology) and BSc (Hons) (Biochemistry) from Universiti Putra Malaysia. Prior to joining PUGScM, she was a lecturer and research coordinator at Faculty of Pharmacy, Lincoln University College. She previously worked as a production scientist at Tessa Therapeutics, a clinical-stage biotechnology company focused on the development of cell therapies for a broad range of cancers. Her primary research areas include stem cells, regenerative medicine, gene therapy, genetics and cancer underlying various diseases such as neuromuscular disorders and diabetes as outcome measures for translational research. She had authored and co-authored various scientific papers and presented scientific papers at national as well as at international conferences. She had obtained numerous research grants as principal investigator and co-researcher as well as supervised several undergraduate and postgraduate students in research. She is also an affiliate member of Young Scientists Network-Academy of Sciences Malaysia (YSN-ASM).
Dr. Wendy Wai Yeng Yeo is currently a lecturer in Biochemistry and Genetics at Perdana University Graduate School of Medicine, Perdana University, Malaysia. She completed her PhD from Universiti Putra Malaysia in Medical Biotechnology with a joint degree (co-tutelle) with Université de Montpellier, France in Health Biology. She did her MSc (Medical Biotechnology) and BSc (Hons) (Biochemistry) from Universiti Putra Malaysia. Prior to joining PUGScM, she was a lecturer and research coordinator at Faculty of Pharmacy, Lincoln University College. She previously worked as a production scientist at Tessa Therapeutics, a clinical-stage biotechnology company focused on the development of cell therapies for a broad range of cancers. Her primary research areas include stem cells, regenerative medicine, gene therapy, genetics and cancer underlying various diseases such as neuromuscular disorders and diabetes as outcome measures for translational research. She had authored and co-authored various scientific papers and presented scientific papers at national as well as at international conferences. She had obtained numerous research grants as principal investigator and co-researcher as well as supervised several undergraduate and postgraduate students in research. She is also an affiliate member of Young Scientists Network-Academy of Sciences Malaysia (YSN-ASM).